Skip to content

Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure

Prediction of Duration of Mechanical Venylation in Patients Wit Acute Hypoxemic Respiratory Failure Usinf Machine Learning Approaches

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06815523
Acronym
PREMIER
Enrollment
1241
Registered
2025-02-07
Start date
2025-02-02
Completion date
2026-06-01
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Hypoxemic Respiratory Failure

Keywords

mechanical ventilation, machine learning, prediction of prolonged mechanical ventilation, outcome

Brief summary

Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (\> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.

Detailed description

Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in intensive care units (ICUs) worldwide. The investigators will assess the value of machine learning (ML) techniques for prediction of prolonged duration (\> or equeal to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. Few studies have investigated the prediction of prolonged MV in patients with AHRF. For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.

Interventions

OTHERMachine learning and logistic regression for the training/testing cohort and validation cohort

Machine learning and logistic regression for the validation cohort

Sponsors

Jesus Villar
Lead SponsorOTHER
Hospital Universitario de Gran Canaria Doctor Negrín
CollaboratorOTHER
Instituto de Salud Carlos III
CollaboratorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* enotracheal intubation puls mechanical ventilation * PaO2/FiO2 ratio \<or = 300 mmHg under MV with PEEP \>or =5 and FiO2 \>or = 0.3

Exclusion criteria

* Brain death patients

Design outcomes

Primary

MeasureTime frameDescription
MV durationup to 100 weeksduration of mechanical ventilation

Countries

Spain

Contacts

STUDY_DIRECTORJesus Villar

Fundacion Canaria Instituto de Investigación Sanitaria de Canarias

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026